ÐÓ°ÉÂÛ̳

Skip to main content
Quest Diagnostics

Risk Estimation of Severe ÐÓ°ÉÂÛ̳-19 Based on Initial Biomarker Assessment Across Racial and Ethnic Groups

Authors:?Kroll MH, Bi C, Salm AE, Szymanski J, Goldstein DY, Wolgast LR, Rosenblatt G, Fox AS, Kapoor H

Arch Pathol Lab Med. 2023 Jun 20. doi: 10.5858/arpa.2023-0039-SA. Online ahead of print.

Specialties:?Infectious disease, ÐÓ°ÉÂÛ̳-19

Related content

Publication
Disparities in SARS CoV 2 Positivity Rates Associations with Race and Ethnicity
Conference Presentation
Laboratory Use of Race, Ethnicity, Ancestry: A Focus on Diagnostic Testing
Publication
Association of ABO Rh with SARS CoV 2 positivity The role of race and ethnicity in a female cohort
Test FAQ
SARS CoV 2 Antibody Testing
Publication
Assessment of the Association of Vitamin D Level With SARS CoV 2 Seropositivity Among Working Age Adults

Our company

Quest? is the brand name used for services offered by ÐÓ°ÉÂÛ̳ and its affiliated companies. ÐÓ°ÉÂÛ̳ and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.? Other affiliates operated under the Quest? brand, such as Quest Consumer Inc., do not provide HIPAA-covered services.?

?

Quest?, Quest Diagnostics?, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks¡ª? and ?¡ªare the property of their respective owners. ? 2025 ÐÓ°ÉÂÛ̳. All rights reserved. Image content features models and is intended for illustrative purposes only.